#ESCCongress – Estudo randomizado | Vacinação precoce contra Influenza após infarto do miocárdio (IM) ou em doença coronariana de alto risco resultou em menor risco de morte por todas as causas, IM ou trombose de stent em comparação com placebo.

Influenza Vaccination after Myocardial Infarction: A Randomized, Double-Blind, Placebo-Controlled, Multicenter Trial – Circulation

Comentários:

IAMI: Influenza Vaccine Beneficial for Post-MI Patients – TCTMD

Influenza Vaccination After Myocardial Infarction – IAMI – American College of Cardiology

Flu vaccine after heart attack reduces risk of death – Cardiovascular Business

Comentário no Twitter

The IAMI trial showed that #fluvaccine within 72 hours of angiography/PCI/hospitalization among patients with recent #cvMI or high-risk coronary heart disease resulted in a salutary effect on CV outcomes at 12 months compared w/ placebo: https://t.co/csnS3G8vsa #ESCCongress pic.twitter.com/5JB4iUmMbV

— American College of Cardiology (@ACCinTouch) August 30, 2021